Previous 10 | Next 10 |
home / stock / tlt / tlt articles
The CEO of Howard Capital Management, Vance Howard, has made predictions about the financial markets that may surprise some investors. Despite the ...
Treasury auctions are coming under scrutiny for the latest signs of stress in the government bond market. What Happened: The U.S. looks to raise hi...
U.S. stocks marked their fourth consecutive week of gains, the longest winning streak since June, in a week marked by thinner trading volumes due t...
Sentiment appears to have reversed course after Tuesday’s pullback, with stock futures pointing to a modestly higher open. The positive shift...
It’s a red day on Wall Street, with stocks retreating as investors assess the latest economic data indicating an increase in jobless claims a...
U.S. stocks trended higher on Wednesday, extending gains in a week marked by two soft inflation reports. After a surprisingly sharp drop in the C...
The markets exhibited a mixed trend Monday, with technology heavyweights experienced a slight downturn as investors adopt a cautious approach ahead...
Stocks rallied on Friday, reversing the negative session from Thursday, which had broken the longest winning streak in over two years, following ha...
The U.S. financial services division of the Industrial and Commercial Bank of China (ICBC) faced a cyberattack, impacting Treasury trades...
News, Short Squeeze, Breakout and More Instantly...
iShares 20+ Year Treasury Bond ETF Company Name:
TLT Stock Symbol:
NASDAQ Market:
TORONTO, ON / ACCESSWIRE / July 8, 2024 / Theralase® Technologies Inc. (" Theralase® " or the " Company ") ( TSXV:TLT )( OTCQB:TLTFF ), a clinical stage pharmaceutical company dedicated to the research and development of light and/or radiation activated Photo Dynamic Compounds (" PDCs ...
TORONTO, ON / ACCESSWIRE / June 20, 2024 / Theralase® Technologies Inc. (" Theralase® " or the " Company ") ( TSXV:TLT )( OTCQB:TLTFF ), a clinical stage pharmaceutical company dedicated to the research and development of light and/or radiation activated small molecules and their formu...
TORONTO, ON / ACCESSWIRE / June 19, 2024 / Theralase® Technologies Inc. (" Theralase® " or the " Company ") ( TSXV:TLT )( OTCQB:TLTFF ), a clinical stage pharmaceutical company dedicated to the research and development of light and/or radiation activated small molecules and their formu...